Innovations & Thérapeutiques en Oncologie
MENUThe combined use of hypofractionated stereotactic radiotherapy and new anticancer drugs Volume 4, issue 3, Mai-June 2018
Export citation
Citation of this article, in the « Vancouver » format:
Stéphanie Servagi Vernat, Estelle Vigneau, Juliette Thariat. The combined use of hypofractionated stereotactic radiotherapy and new anticancer drugs. Innovations & Thérapeutiques en Oncologie. 2018;4(3):146-151. doi:10.1684/ito.2018.0118